Didem Melis Oztas

Dr. Didem Melis Oztas


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2021 in Annals of Vascular Surgery
Verified
Journal Article
Closed access
OROrhan Rodoplu
Orhan Rodoplu
DODidem Melis Oztas
Didem Melis Oztas
MMMert Meric
Mert Meric
MBMetin Onur Beyaz
Metin Onur Beyaz
MUMustafa Ozer Ulukan
Mustafa Ozer Ulukan
MUMurat Ugurlucan
Murat Ugurlucan

27 May 2021 in Surgical Innovation
Verified
Journal Article
Closed access
PDF file
MBMetin Onur Beyaz
Metin Onur Beyaz
DODidem Melis Oztas
Didem Melis Oztas
MUMustafa Ozer Ulukan
Mustafa Ozer Ulukan
HAHasan Murat Arslan
Hasan Murat Arslan
OUOrcun Unal
Orcun Unal
MUMurat Ugurlucan
Murat Ugurlucan
Introduction: In the current study, we present single surgeon experience of a new radiofrequency ablation system, the catheter, and the device. Patients and Methods: The new system, which comprises a generator and an intervally illuminated radiofrequency ablation catheter, was used for the treatment of 272 consecutive patients with chronic venous insufficiency of the great saphenous vein between November 2017 and October 2018. Mean age of the patients was 53.40 ± 11.91 years. Mean saphenous vein diameter was 8.51 ± 2.45 mm. Bilateral great saphenous vein reflux disease was present in 19% (51 cases) of the patients. At the end of the procedure, the closure of the great saphenous vein was confirmed with Doppler ultrasonography. Results: Procedures could be successfully performed in all, except 1 obese (BMI> 30 kg/m2) male patient. At the 3rd month, outpatient clinic follow-up control Doppler USG revealed successful ablation of the treated great saphenous vein in 260 patients (96%), whereas in 12 cases (4%), there was continuing reflux. The diameters of the saphenous veins in these patients ranged between 6.9 mm and 19.5 (mean: 10.68 ± 3.41) mm. Ten patients could be treated successfully with ablation with the same device controlled both at the interventional section as well as on the 3rd month outpatient clinic follow-up. The remaining patients underwent high ligation of the great saphenous vein. Paresthesia occurred in 1 patient and had been permanent. Hematoma occurred in a male patient and resolved spontaneously. Conclusion: Preliminary results of our new radiofrequency ablation device with illumination guidance for the treatment of great saphenous vein reflux disease indicated successful results with enhanced physician utilization, comfort, and reliability.

22 October 2020 in Phlebology: The Journal of Venous Disease
Verified
Journal Article
Closed access
PDF file
OROrhan Rodoplu
Orhan Rodoplu
CYCenk Eray Yildiz
Cenk Eray Yildiz
DODidem Melis Oztas
Didem Melis Oztas
MBMetin Onur Beyaz
Metin Onur Beyaz
MUMustafa Ozer Ulukan
Mustafa Ozer Ulukan
MUMurat Ugurlucan
Murat Ugurlucan
Objective: In this study, we aimed to evaluate the efficiency of rotational thrombectomy device in pharmaco-mechanical thrombolysis for symptomatic acute ilio-femoral deep vein thrombosis. Materials and methods: Between August 2013 and May 2018,82 patients with acute deep vein thrombosis comprising the iliofemoral segment whom underwent Pharmaco-mechanical thrombolysis were evaluated retrospectively. The Cleaner thrombectomy device was used. The resolution of thrombi was examined and graded. Development of post-thrombotic syndrome was assessed with Villalta scores. Results: 75 patients (91.4%) had complete thrombus resolution. Between 50–99% resolution was noted in 6 patients (7.4%) and in one (1.2%) case less than %50 thrombus resolution was obtained. Seventy-five patients (91%) of the cohort could be treated in a single session; 7 patients (8.6%) required reintervention(s). Although improved post-thrombotic syndrome rates were lower at the short term, Villalta scores gradually increased during follow up. Conclusions: In conclusion, Pharmaco-mechanical thrombolysis with Cleaner thrombectomy device is a safe and beneficial method for the treatment of acute iliofemoral deep vein thrombosis. Long term follow up data of large volume multicenter studies are warranted.

15 December 2014 in Case Reports in Medicine
Verified
Journal Article
Open access
PDF file
MUMurat Ugurlucan
Murat Ugurlucan
OSOmer Ali Sayin
Omer Ali Sayin
MFMatthias Felten
Matthias Felten
DODidem Melis Oztas
Didem Melis Oztas
MCMehmet Semih Cakir
Mehmet Semih Cakir
EDEnver Dayioglu
Enver Dayioglu
Mediastinal cysts are extremely rare clinical disorders. They usually have a pericardial origin. In this report, we present a 27-year-old male patient with a mediastinal bronchogenic cyst together with clinical presentation and management of the pathology.

2 July 2020 in Cardiology in the Young
Verified
Journal Article
Open access
PDF file
MUMurat Ugurlucan
Murat Ugurlucan
YYYahya Yildiz
Yahya Yildiz
DODidem Melis Oztas
Didem Melis Oztas
SCSenay Coban
Senay Coban
MBMetin Onur Beyaz
Metin Onur Beyaz
HTHalil Turkoglu
Halil Turkoglu
Introduction: In this report, we aim to present our algorithm and results of patients with congenital cardiac disorders who underwent surgical or interventional procedures during the peak phase of the pandemics in our country.Patients and methods: The first COVID-19 case was diagnosed in Turkey on 11 March, 2020, and the peak phase seemed to end by the end of April. All the patients whom were referred, treated, or previously operated but still at the hospital during the peak phase of COVID-19 pandemics in the country were included into this retrospective study. Patient’s diagnosis, interventions, adverse events, and early post-procedural courses were studied.Results: Thirty-one patients with various diagnoses of congenital cardiovascular disorders were retrospectively reviewed. Ages of the patients ranged between 2 days and 16 years. Seventeen cases were males and 14 cases were females. Elective cases were postponed. Priority was given to interventional procedures, and five cases were treated percutaneously. Palliative procedures were preferred in patients whom presumably would require long hospital stay. Corrective procedures were not hesitated in prioritised stable patients. Mortality occurred in one patient. Eight patients out of 151 ICU admissions were diagnosed with COVID-19, and they were transferred to COVID-19 ICU immediately. Three nurses whom also took care of the paediatric cases became infected with SARS-CoV-2; however, the children did not catch the disease.Conclusion: Mandatory and emergent congenital cardiac percutaneous and surgical procedures may be performed with similar postoperative risks as there are no pandemics with meticulous care and preventive measures.

19 February 2020 in Interactive CardioVascular and Thoracic Surgery
Verified
Journal Article
Closed access
DODidem Melis Oztas
Didem Melis Oztas
MUMurat Ugurlucan
Murat Ugurlucan
MBMetin Onur Beyaz
Metin Onur Beyaz
MUMustafa Ozer Ulukan
Mustafa Ozer Ulukan
OUOrcun Unal
Orcun Unal
UAUfuk Alpagut
Ufuk Alpagut
OBJECTIVES: Treating aortic arch aneurysms with conventional open surgical and endovascular stent graft procedures is challenging due to the complex anatomy of the arch and the arteries arising from it that nourish the brain. Cerebral protection is of the utmost importance during the treatment of thoracic aneurysms involving the aortic arch. METHODS: Between May 2014 and November 2018, 7 patients with thoracic aortic aneurysms involving the aortic arch who underwent aortic arch cervical debranching with our technique were reviewed retrospectively. Because all the patients being considered for conventional surgical aortic arch replacement had serious comorbidities, they were selected to receive hybrid therapy. The mean age of the patients was 71.2 ± 9.4 years. One patient was a woman and 6 patients were men. One patient was given general anaesthesia; the remaining 6 patients had a regional block. A crossover temporary bypass was performed between the external carotid arteries with a 6-mm polytetrafluoroethylene graft for cerebral protection in all patients. Thoracic endovascular aortic repair (TEVAR) was successfully performed in all patients except 1 following debranching. RESULTS: Neurological complications did not occur during the procedures. Patients were followed for a mean of 18.3 ± 4.9 months. One female patient died of exacerbating chronic obstructive pulmonary disease within the first follow-up year. Three other patients died: 1 died of natural causes; 1 died of pneumonia followed by multiorgan failure; and 1 died of myocardial infarction during the mid-term follow-up period. The remaining patients are still being followed and are event free. CONCLUSIONS: Endovascular treatment of thoracic aortic diseases involving the aortic arch is facilitated when the aortic arch is debranched. Our cerebral protection method with a temporary crossover bypass between the external carotid arteries provides continuous pulsatile blood flow to the brain; hence, neurologically, it is a reliable procedure. The follow-up results of the patients who underwent aortic arch cervical debranching followed by TEVAR depended on their comorbidities.